KOSTIUKOVA, N.I.; FISHCHUK, L.Ye.; ROSSOKHA, Z.I.; MEDVEDIEVA, N.L.; ANDREIEVA, S.V.; BLOSHCHINSKA, S.V.; POPOVA, O.F.; VYDYBORETS, S.V.; GOROVENKO, N.G. CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma. Experimental Oncology, [S. l.], v. 43, n. 4, p. 336–340, 2023. DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-4.16924. Disponível em: https://exp-oncology.com.ua/index.php/Exp/article/view/2021-4-7. Acesso em: 26 nov. 2025.